Brief: Australian Clinical Labs Says It Expects FY27 Revenue Of A$745-765 Million
17/08/2026 02:24
BRIEF-Australian Clinical Labs Says It Expects FY27 Revenue Of A$745-765 Million Aug 17 (Reuters) - Australian Clinical Labs Limited ACL.AX:
SEES FY27 REVENUE OF A$745-765 MILLION
SEES FY27 UNDERLYING EBIT OF A$67-73 MILLION
Further company coverage: ACL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Australian Clinical Labs
See all newsBrief: Australian Clinical Labs Appoints Deloitte As Auditor
Australia's Optiscan rises after imaging more than 80 cases in ACL study
Australian Clinical Labs falls to over two-week low on trading ex-dividend
Australian Clinical Labs at 6-month high on upbeat full-year results, guidance
Brief: Australian Clinical Labs Says It Expects FY27 Revenue Of A$745-765 Million